PFKFB3促进鼻咽癌细胞增殖和转移的作用及潜在机制研究OA
Role of PFKFB3 in promoting proliferation and metastasis of nasopha-ryngeal carcinoma cells and its underlying molecular mechanism
目的:探讨6-磷酸果糖-2-激酶/果糖2,6-二磷酸酶3(6-phosphofructo-2-kinase/fructose-2,6-bisphos-phatase 3,PFKFB3)对鼻咽癌细胞增殖和转移的影响,并分析其相关的差异表达蛋白及潜在信号通路.方法:构建PFKFB3过表达(oe-)和干扰(sh-)慢病毒,通过实时无标记细胞分析、创伤愈合及Transwell实验检测细胞表型;构建裸鼠皮下移植瘤及足垫-腹股沟淋巴结转移模型,评估PFKFB3对体内肿瘤生长和转移的影响;采用非标记数据非依赖性采集定量蛋白质组学技术筛选差异表达蛋白并进行KEGG通路富集分析;通过Western blot和免疫组织化学技术验证关键蛋白表达.结果:在细胞水平,oe-PFKFB3显著增强鼻咽癌细胞增殖、迁移和侵袭能力,并下调E-cadherin,上调X连锁凋亡抑制蛋白(X-linked inhibitor of apoptosis protein,XIAP)、增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)、survivin、N-cadherin、vimentin、occludin和膜联蛋白A1(annexin A1,ANXA1)的表达(P<0.05或P<0.01);sh-PFKFB3作用相反.在动物水平,oe-PFKFB3促进裸鼠移植瘤生长,并上调肿瘤组织中XIAP、PCNA、N-cadherin、vimentin和ANXA1的表达;sh-PFKFB3则抑制肿瘤生长与转移,下调上述蛋白和survivin,上调E-cad-herin的表达(P<0.05或P<0.01).蛋白质组学结果显示,sh-PFKFB3后共筛选出407个差异表达蛋白,这些蛋白显著富集于Notch、Hippo、Rap1及转化生长因子β(transforming growth factor-β,TGF-β)等信号通路,具体表现为免疫球蛋白κJ区重组信号结合蛋白(recombination signal binding protein for immunoglobulin κJ region,RBPJ)、纤溶酶原激活物抑制剂1(plasminogen activator inhibitor-1,PAI-1/SERPINE1)、原癌基因酪氨酸蛋白激酶SRC和肌动蛋白抑制蛋白2(profilin 2)等蛋白表达下调,而TGF-β受体2(TGF-β receptor 2,TGFBR2)和细胞周期蛋白依赖性激酶4抑制因子B(cyclin-dependent kinase 4 inhibitor B,CDKN2B)等蛋白表达上调.免疫组织化学实验在移植瘤组织中验证了这些关键蛋白的表达变化趋势(P<0.05或P<0.01).结论:PFKFB3在鼻咽癌中发挥促癌作用,与鼻咽癌细胞增殖、迁移、侵袭及体内转移能力密切相关.PFKFB3的异常表达可能通过影响Notch、Rap1、Hippo及TGF-β等多条信号通路中的关键节点蛋白,参与鼻咽癌的恶性进展.
AIM:To investigate the effects of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(PFKFB3)on the proliferation and metastasis of nasopharyngeal carcinoma(NPC)cells,and to analyze its protein expres-sion profile and associated signaling pathways.METHODS:PFKFB3 overexpression(oe-)and knockdown(sh-)lentivi-ruses were constructed,and their effects were analyzed using real-time cellular analysis(RTCA)and wound-healing and Transwell assays.Subcutaneous xenograft and footpad-inguinal lymph node metastasis models were established in nude mice to evaluate the effects of PFKFB3 on tumor growth and metastasis in vivo.Label-free data-independent acquisition-based quantitative proteomics was used to identify differentially expressed proteins(DEPs)and enriched pathways.Key DEPs were verified using Western blot and immunohistochemistry(IHC).RESULTS:Overexpression of PFKFB3 signifi-cantly enhanced NPC cell proliferation,migration,and invasion in vitro,together with down-regulation of E-cadherin and up-regulation of X-linked inhibitor of apoptosis protein(XIAP),proliferating cell nuclear antigen(PCNA),survivin,N-cadherin,vimentin,occludin,and annexin A1(ANXA1)(P<0.05 or P<0.01).The opposite effects were observed in PFKFB3-knockdown cells.In vivo,PFKFB3 overexpression promoted tumor growth and up-regulated XIAP,PCNA,N-cadherin,vimentin,and ANXA1 in tumor tissues,whereas knockdown inhibited tumor growth and metastasis,down-regu-lated the above proteins and survivin,and up-regulated E-cadherin(P<0.05 or P<0.01).Proteomic analysis identified 407 DEPs in PFKFB3-knockdown cells,and enrichment analyses indicated involvement of these proteins in the Notch,Hippo,Rap1,and transforming growth factor-β(TGF-β)signaling pathways.Specifically,the levels of pro-oncogenic proteins such as recombination signal binding protein for immunoglobulin κJ region(RBPJ),plasminogen activator inhibi-tor-1(PAI-1/SERPINE1),proto-oncogene tyrosine-protein kinase SRC,and profilin 2 were decreased,whereas those of tumor-suppressive proteins such as TGF-β receptor 2(TGFBR2)and cyclin-dependent kinase 4 inhibitor B(CDKN2B)were increased.These changes in expression were verified using IHC in xenograft tissues(P<0.05 or P<0.01).CON-CLUSION:PFKFB3 functions as an oncogene in NPC,with expression levels significantly correlated with proliferation,migration,invasion,and in vivo metastasis of NPC cells.Aberrant expression of PFKFB3 may promote malignant progres-sion of NPC by regulating key proteins in signaling pathways,such as the Notch,Rap1,Hippo and TGF-β pathways.
史红健;刘洁;伍永慧;张文青;何兰;何迎春
湖南中医药大学,湖南 长沙 410208||中医药防治眼耳鼻咽喉疾病湖南省重点实验室,湖南 长沙 410208湖南中医药大学,湖南 长沙 410208||中医药防治眼耳鼻咽喉疾病湖南省重点实验室,湖南 长沙 410208湖南中医药大学,湖南 长沙 410208||中医药防治眼耳鼻咽喉疾病湖南省重点实验室,湖南 长沙 410208湖南中医药大学,湖南 长沙 410208||中医药防治眼耳鼻咽喉疾病湖南省重点实验室,湖南 长沙 410208湖南中医药大学,湖南 长沙 410208||湖南中医药大学第一附属医院,湖南 长沙 410007湖南中医药大学,湖南 长沙 410208||中医药防治眼耳鼻咽喉疾病湖南省重点实验室,湖南 长沙 410208
医药卫生
6-磷酸果糖-2-激酶/果糖2,6-二磷酸酶3鼻咽癌细胞增殖肿瘤转移蛋白组学
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3nasopharyngeal carcinomacell prolif-erationmetastasisproteomics
《中国病理生理杂志》 2026 (8)
1527-1537,11
国家自然科学基金资助项目(No.82305329No.82505683)湖南省卫生健康委科研计划课题(No.D202307017740)长沙市指导性科技计划项目(No.kzd22008)
评论